La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Antagoniste »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antagonisme < Antagoniste < Antagoniste analgésique narcotique  Facettes :

List of bibliographic references indexed by Antagoniste

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
001D20 (2010) Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada]Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
002062 (2009) WEI SONG [Canada] ; Amar Patel [Canada] ; Hamid Y. Qureshi [Canada] ; DONG HAN [Canada] ; Hyman M. Schipper [Canada] ; Hemant K. Paudel [Canada]The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells
002F05 (2003) Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis]Renaissance of amantadine in the treatment of Parkinson's disease
002F15 (2003) Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Paul J. Bedard [Canada]Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems
003054 (2002) H. Uri Saragovi [Canada] ; Maria Clara Zaccaro [Canada]Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites
003058 (2002) Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie]Role of serotonin2C receptors in the control of brain dopaminergic function
003103 (2002) Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment
003560 (2000) E. F. Field [Canada] ; I. Q. Whishaw [Canada] ; S. M. Pellis [Canada]Sex differences in catalepsy : evidence for hormone-dependent postural mechanisms in haloperidol-treated rats
003596 (2000) ABDALLAH HADJ TAHAR [Canada] ; N. Belanger [Canada] ; E. Bangassoro [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys
003827 (1999) V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
003839 (1999) R. Grondin [Canada] ; P. J. Bedard [Canada] ; A. Hadj Tahar [Canada] ; L. Gregoire [Canada] ; A. Mori [Japon] ; H. Kase [Japon]Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
003C75 (1997) D. D. Newman [Canada] ; N. Rajakumar ; B. A. Flumerfelt ; A. J. Stoessl [Canada]A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease
003E89 (1996) N. Galvez-Jimenez [Canada] ; A. E. Lang [Canada]Perioperative problems in Parkinson's disease and their management : Apomorphine with rectal domperidone
004083 (1995) J.-A. St-Pierre [Canada] ; P. J. BedardSystemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine
004292 (1994) K. H. Jhamandas [Canada] ; R. J. Boegman [Canada] ; R. J. BeningerThe 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits : modulation by endogenous excitotoxin antagonists
004293 (1994) T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. GrimesSymptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride
004A66 (1989) Paul J. Bédard [Canada] ; René Boucher [Canada]Effect of D1 receptor stimulation in normal and MPTP monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Antagoniste" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Antagoniste" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Antagoniste
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022